WHO PV workshop on active surveillance
  • Home
  • Webinar
    • Objectives
    • Manual (compiled modules)
    • Modules
    • Agenda
  • Speakers
  • Sign in
#
Introduction
#
description and general safety considerations for implementation
#
Stakeholders in COVID-19 vaccine safety surveillance
#
Establishing surveillance systems in countries using COVID-19 vaccines
#
Responding to adverse events following COVID-19 immunization (AEFIs)
#
Establishing active surveillance systems for adverse events of special interest during COVID-19 vaccine introduction
#
Safety data management systems in countries using COVID-19 vaccines
#
Engaging with the pharmaceutical industry for COVID-19 vaccine safety surveillance
#
 Regulatory reliance and work-sharing
#
 COVID-19 vaccine safety communication 
Copyright © World Health Organization
Powered by Odoo - Create a free website